$ALXN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALEXION PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ALEXION PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 14 15 16 17 18 19 20 21 22 ... 22 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.81 | 100 | 7,881 | 13,949 | 14 K to 13.9 K (-0.71 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 78.95 | 11,000 | 868,450 | 14,049 | 3 K to 14 K (+360.77 %) |
Sep 25 2007 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Sell | S | 65.87 | 5 | 329 | 28,544 | 28.5 K to 28.5 K (-0.02 %) |
Sep 25 2007 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Sell | S | 63.00 | 23 | 1,449 | 28,549 | 28.6 K to 28.5 K (-0.08 %) |
Sep 25 2007 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Sell | S | 63.03 | 100 | 6,303 | 28,572 | 28.7 K to 28.6 K (-0.35 %) |
Sep 25 2007 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Sell | S | 63.04 | 1,100 | 69,344 | 28,672 | 29.8 K to 28.7 K (-3.69 %) |
Sep 25 2007 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Sell | S | 63.05 | 777 | 48,990 | 29,772 | 30.5 K to 29.8 K (-2.54 %) |
Sep 25 2007 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Sell | S | 63.09 | 200 | 12,618 | 30,549 | 30.7 K to 30.5 K (-0.65 %) |
Sep 25 2007 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Sell | S | 63.11 | 57 | 3,597 | 30,749 | 30.8 K to 30.7 K (-0.19 %) |
Sep 25 2007 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Sell | S | 63.18 | 200 | 12,636 | 30,806 | 31 K to 30.8 K (-0.65 %) |
Sep 25 2007 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Sell | S | 63.26 | 100 | 6,326 | 31,006 | 31.1 K to 31 K (-0.32 %) |
Sep 25 2007 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Sell | S | 63.40 | 1,600 | 101,440 | 31,106 | 32.7 K to 31.1 K (-4.89 %) |
Sep 12 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 65.31 | 514 | 33,569 | 15,000 | 15.5 K to 15 K (-3.31 %) |
Sep 12 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 65.31 | 209 | 13,650 | 20,303 | 20.5 K to 20.3 K (-1.02 %) |
Sep 12 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 65.18 | 200 | 13,036 | 105,209 | 105.4 K to 105.2 K (-0.19 %) |
Sep 12 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 65.27 | 9 | 587 | 105,409 | 105.4 K to 105.4 K (-0.01 %) |
Aug 24 2007 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Option Exercise | M | 10.38 | 2,000 | 20,760 | 0 | |
Aug 24 2007 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Sell | S | 58.99 | 100 | 5,899 | 58,500 | 58.6 K to 58.5 K (-0.17 %) |
Aug 24 2007 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Sell | S | 58.98 | 400 | 23,592 | 58,600 | 59 K to 58.6 K (-0.68 %) |
Aug 24 2007 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Buy | M | 10.38 | 2,000 | 20,760 | 59,000 | 57 K to 59 K (+3.51 %) |
Aug 01 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Option Exercise | M | 10.50 | 4,250 | 44,625 | 0 | |
Aug 01 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 58.75 | 200 | 11,750 | 105,418 | 105.6 K to 105.4 K (-0.19 %) |
Aug 01 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 58.76 | 1,300 | 76,388 | 105,618 | 106.9 K to 105.6 K (-1.22 %) |
Aug 01 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 58.77 | 200 | 11,754 | 106,918 | 107.1 K to 106.9 K (-0.19 %) |
Aug 01 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 58.78 | 100 | 5,878 | 107,118 | 107.2 K to 107.1 K (-0.09 %) |
Aug 01 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 58.79 | 400 | 23,516 | 107,218 | 107.6 K to 107.2 K (-0.37 %) |
Aug 01 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 58.81 | 100 | 5,881 | 107,618 | 107.7 K to 107.6 K (-0.09 %) |
Aug 01 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 58.83 | 100 | 5,883 | 107,718 | 107.8 K to 107.7 K (-0.09 %) |
Aug 01 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 58.70 | 1,850 | 108,595 | 107,818 | 109.7 K to 107.8 K (-1.69 %) |
Aug 01 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Buy | M | 10.50 | 4,250 | 44,625 | 109,668 | 105.4 K to 109.7 K (+4.03 %) |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 10.74 | 2,251 | 24,176 | 4,500 | |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 10.74 | 5,249 | 56,374 | 0 | |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 9.50 | 8,750 | 83,125 | 0 | |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 9.00 | 8,750 | 78,750 | 0 | |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 56.50 | 20,484 | 1,157,346 | 20,512 | 41 K to 20.5 K (-49.97 %) |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 56.90 | 4,516 | 256,960 | 40,996 | 45.5 K to 41 K (-9.92 %) |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.74 | 2,251 | 24,176 | 45,512 | 43.3 K to 45.5 K (+5.20 %) |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.74 | 5,249 | 56,374 | 47,763 | 42.5 K to 47.8 K (+12.35 %) |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 9.50 | 8,750 | 83,125 | 42,514 | 33.8 K to 42.5 K (+25.92 %) |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 9.00 | 8,750 | 78,750 | 33,764 | 25 K to 33.8 K (+34.98 %) |
Jul 12 2007 | ALXN | ALEXION PHARMACEUT ... | Coissac Patrice | GM/President ALXN S ... | Option Exercise | A | 47.66 | 10,000 | 476,600 | 10,000 | |
Jul 12 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Option Exercise | A | 47.66 | 12,500 | 595,750 | 12,500 | |
Jul 12 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | A | 47.66 | 14,500 | 691,070 | 14,500 | |
Jul 12 2007 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Option Exercise | A | 47.66 | 18,000 | 857,880 | 18,000 | |
Jul 12 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Option Exercise | A | 47.66 | 20,000 | 953,200 | 20,000 | |
Jul 12 2007 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | A | 47.66 | 42,500 | 2,025,550 | 42,500 | |
Jun 01 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 9.50 | 8,750 | 83,125 | 0 | |
Jun 01 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 9.00 | 16,250 | 146,250 | 8,750 | |
Jun 01 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 48.50 | 25,000 | 1,212,500 | 25,014 | 50 K to 25 K (-49.99 %) |
Jun 01 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 9.50 | 8,750 | 83,125 | 50,014 | 41.3 K to 50 K (+21.20 %) |
Jun 01 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 9.00 | 16,250 | 146,250 | 41,264 | 25 K to 41.3 K (+64.96 %) |
Jun 13 2007 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | M | 32.50 | 10,000 | 325,000 | 0 | |
Jun 13 2007 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | M | 19.73 | 7,500 | 147,975 | 0 | |
Jun 13 2007 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | M | 22.21 | 7,500 | 166,575 | 0 | |
Jun 13 2007 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | M | 17.05 | 5,000 | 85,250 | 2,500 | |
Jun 13 2007 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | M | 10.74 | 2,666 | 28,633 | 1,334 | |
Jun 13 2007 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | M | 15.58 | 2,500 | 38,950 | 5,000 | |
Jun 13 2007 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | M | 32.50 | 10,000 | 325,000 | 82,743 | 72.7 K to 82.7 K (+13.75 %) |
Jun 13 2007 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | M | 19.73 | 7,500 | 147,975 | 72,743 | 65.2 K to 72.7 K (+11.50 %) |
Jun 13 2007 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | M | 22.21 | 7,500 | 166,575 | 65,243 | 57.7 K to 65.2 K (+12.99 %) |
Jun 13 2007 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | M | 17.05 | 5,000 | 85,250 | 57,743 | 52.7 K to 57.7 K (+9.48 %) |
Jun 13 2007 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | M | 10.74 | 2,666 | 28,633 | 52,743 | 50.1 K to 52.7 K (+5.32 %) |
Jun 13 2007 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | M | 15.58 | 2,500 | 38,950 | 50,077 | 47.6 K to 50.1 K (+5.25 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.02 | 1,500 | 70,530 | 14,152 | 15.7 K to 14.2 K (-9.58 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.03 | 3,540 | 166,486 | 15,652 | 19.2 K to 15.7 K (-18.45 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.04 | 1,660 | 78,086 | 19,192 | 20.9 K to 19.2 K (-7.96 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.05 | 2,100 | 98,805 | 20,852 | 23 K to 20.9 K (-9.15 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.06 | 1,700 | 80,002 | 22,952 | 24.7 K to 23 K (-6.90 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.07 | 1,179 | 55,496 | 24,652 | 25.8 K to 24.7 K (-4.56 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.08 | 3,346 | 157,530 | 25,831 | 29.2 K to 25.8 K (-11.47 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.09 | 5,140 | 242,043 | 29,177 | 34.3 K to 29.2 K (-14.98 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.10 | 9,019 | 424,795 | 34,317 | 43.3 K to 34.3 K (-20.81 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | P | 47.11 | 5,023 | 236,634 | 43,336 | 48.4 K to 43.3 K (-10.39 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.12 | 4,961 | 233,762 | 48,359 | 53.3 K to 48.4 K (-9.30 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.13 | 3,423 | 161,326 | 53,320 | 56.7 K to 53.3 K (-6.03 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.14 | 2,977 | 140,336 | 56,743 | 59.7 K to 56.7 K (-4.98 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.15 | 5,660 | 266,869 | 59,720 | 65.4 K to 59.7 K (-8.66 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.16 | 3,240 | 152,798 | 65,380 | 68.6 K to 65.4 K (-4.72 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.17 | 2,500 | 117,925 | 68,620 | 71.1 K to 68.6 K (-3.52 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.18 | 2,900 | 136,822 | 71,120 | 74 K to 71.1 K (-3.92 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.19 | 975 | 46,010 | 74,020 | 75 K to 74 K (-1.30 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.20 | 4,025 | 189,980 | 74,995 | 79 K to 75 K (-5.09 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.21 | 1,181 | 55,755 | 79,020 | 80.2 K to 79 K (-1.47 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.22 | 2,372 | 112,006 | 80,201 | 82.6 K to 80.2 K (-2.87 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.23 | 1,422 | 67,161 | 82,573 | 84 K to 82.6 K (-1.69 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.24 | 800 | 37,792 | 84,005 | 84.8 K to 84 K (-0.94 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.25 | 800 | 37,800 | 84,805 | 85.6 K to 84.8 K (-0.93 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.26 | 1,378 | 65,124 | 85,605 | 87 K to 85.6 K (-1.58 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.27 | 800 | 37,816 | 86,983 | 87.8 K to 87 K (-0.91 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.28 | 2,600 | 122,928 | 87,783 | 90.4 K to 87.8 K (-2.88 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.29 | 3,100 | 146,599 | 90,383 | 93.5 K to 90.4 K (-3.32 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.30 | 1,700 | 80,410 | 93,483 | 95.2 K to 93.5 K (-1.79 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.31 | 1,322 | 62,544 | 95,183 | 96.5 K to 95.2 K (-1.37 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.32 | 300 | 14,196 | 96,505 | 96.8 K to 96.5 K (-0.31 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.33 | 3,400 | 160,922 | 96,805 | 100.2 K to 96.8 K (-3.39 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.34 | 900 | 42,606 | 100,205 | 101.1 K to 100.2 K (-0.89 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.35 | 1,300 | 61,555 | 101,105 | 102.4 K to 101.1 K (-1.27 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.36 | 2,400 | 113,664 | 102,405 | 104.8 K to 102.4 K (-2.29 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.37 | 1,230 | 58,265 | 104,805 | 106 K to 104.8 K (-1.16 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.38 | 570 | 27,007 | 106,035 | 106.6 K to 106 K (-0.53 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.39 | 800 | 37,912 | 106,605 | 107.4 K to 106.6 K (-0.74 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.40 | 100 | 4,740 | 107,405 | 107.5 K to 107.4 K (-0.09 %) |
May 09 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Option Exercise | M | 10.50 | 9,375 | 98,438 | 9,375 | |
May 09 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 47.00 | 9,375 | 440,625 | 105,418 | 114.8 K to 105.4 K (-8.17 %) |
May 09 2007 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Buy | M | 10.50 | 9,375 | 98,438 | 114,793 | 105.4 K to 114.8 K (+8.89 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 41.15 | 625 | 25,719 | 7,055 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 32.70 | 1,875 | 61,313 | 4,006 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 20.72 | 3,750 | 77,700 | 8,250 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 27.58 | 2,250 | 62,055 | 3,750 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 20.38 | 3,000 | 61,140 | 1,125 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 16.10 | 140 | 2,254 | 2,250 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 16.10 | 7,360 | 118,496 | 2,250 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 23.29 | 3,090 | 71,966 | 2,595 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 23.29 | 8,160 | 190,046 | 1,155 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 17.67 | 5,625 | 99,394 | 1,250 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 17.67 | 3,125 | 55,219 | 0 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 10.74 | 1,875 | 20,138 | 0 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 21.00 | 416 | 8,736 | 0 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 21.00 | 25,584 | 537,264 | 0 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 9.50 | 15,000 | 142,500 | 0 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | M | 9.00 | 22,000 | 198,000 | 0 | |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.51 | 1,100 | 52,261 | 107,505 | 108.6 K to 107.5 K (-1.01 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.55 | 200 | 9,510 | 108,605 | 108.8 K to 108.6 K (-0.18 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.56 | 500 | 23,780 | 108,805 | 109.3 K to 108.8 K (-0.46 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.57 | 400 | 19,028 | 109,305 | 109.7 K to 109.3 K (-0.36 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.60 | 700 | 33,320 | 109,705 | 110.4 K to 109.7 K (-0.63 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.62 | 200 | 9,524 | 110,405 | 110.6 K to 110.4 K (-0.18 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.63 | 1,000 | 47,630 | 110,605 | 111.6 K to 110.6 K (-0.90 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.66 | 400 | 19,064 | 111,605 | 112 K to 111.6 K (-0.36 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.72 | 200 | 9,544 | 112,005 | 112.2 K to 112 K (-0.18 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.73 | 100 | 4,773 | 112,205 | 112.3 K to 112.2 K (-0.09 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.77 | 100 | 4,777 | 112,305 | 112.4 K to 112.3 K (-0.09 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.79 | 100 | 4,779 | 112,405 | 112.5 K to 112.4 K (-0.09 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.80 | 200 | 9,560 | 112,505 | 112.7 K to 112.5 K (-0.18 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.83 | 200 | 9,566 | 112,705 | 112.9 K to 112.7 K (-0.18 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.87 | 500 | 23,935 | 112,905 | 113.4 K to 112.9 K (-0.44 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.89 | 1,000 | 47,890 | 113,405 | 114.4 K to 113.4 K (-0.87 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.92 | 400 | 19,168 | 114,405 | 114.8 K to 114.4 K (-0.35 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 47.94 | 100 | 4,794 | 114,805 | 114.9 K to 114.8 K (-0.09 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 48.00 | 1,495 | 71,760 | 114,905 | 116.4 K to 114.9 K (-1.28 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 48.01 | 200 | 9,602 | 116,390 | 116.6 K to 116.4 K (-0.17 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 48.02 | 800 | 38,416 | 116,590 | 117.4 K to 116.6 K (-0.68 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 48.03 | 532 | 25,552 | 117,390 | 117.9 K to 117.4 K (-0.45 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 48.04 | 5 | 240 | 117,922 | 117.9 K to 117.9 K (0.00 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Sell | S | 48.06 | 100 | 4,806 | 117,927 | 118 K to 117.9 K (-0.08 %) |
May 31 2007 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Buy | M | 0.00 | 103,875 | 0 | 118,027 | 14.2 K to 118 K (+734.00 %) |
May 07 2007 | ALXN | ALEXION PHARMACEUT ... | Waeger Ruedi E | Director | Option Exercise | A | 43.36 | 7,500 | 325,200 | 7,500 | |
May 07 2007 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Option Exercise | A | 43.36 | 7,500 | 325,200 | 7,500 | |
May 07 2007 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | A | 43.36 | 7,500 | 325,200 | 7,500 | |
May 07 2007 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Option Exercise | A | 43.36 | 7,500 | 325,200 | 7,500 |